May 24, 2023 03:04 PM EDT

Purdue Pharma nabs court approval for $397M sale of consumer health unit

Nicole DeFeudis

Editor

A federal bankruptcy judge on Tuesday approved Purdue Pharma’s $397 million sale of its consumer health unit to a subsidiary of Arcadia Consumer Healthcare. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Purdue Pharma nabs court approval for $397M sale of consumer health unit

Nicole DeFeudis

Editor

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Boehringer’s updated results in HER2-mutated lung cancer impress

Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny

Scholar Rock names new CEO, adds biotech veterans in C-suite rebuild

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B

GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?

Pur­due Phar­ma nabs court ap­proval for $397M sale of con­sumer health unit

Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Purdue Pharma nabs court approval for $397M sale of consumer health unit